Navigation Links
Drug Companies Hit Out at Thai Generic Drug Scheme

Thailand's government is at loggerheads with the pharmaceutical industry over its decision to issue compulsory licences for generic medicines. //

While Thailand argues it will make cheap generic drugs more widely available to its citizens, drug companies maintain that the plan undermines patent law and discourages foreign investment.

"We were disappointed by the announcement," Bangkok CEO of US drug firm, Merck Sharp and Dome, Christian Sellars, told Radio Australia's Karon Snowdon.

"We have been working with the Thai government to see what can be done in order to ensure that the patients get access to the products."

Compulsory licences have been issued to cover three medications which allow cheaper copies to be made or imported, including an HIV drug made by the giant US firm Merck Sharp and Dome.

Thailand's Ministry of Public Health is expected to expand the list of medicines covered by compulsory licence, using the public health rules of the World Trade Organisation.

Thailand encourages firms to lower prices

Last week Merck lowered the price of its HIV treatment, known as Efavirenz, by 14 per cent.

Mr Sellers says his firm provides the drug at cost price in developing countries and in middle income countries hardest hit by the epidemic.

But Thai Health Minister Mongkol na Songkhla says Merck lowered its prices too late and the compulsory licence issued will remain in force.

He is having talks with other companies who he says can avoid a compulsory licence by lowering their prices to the government's satisfaction.

Aid bodies dismiss drug firm claims

The Thai government's stance has the full support of non-governmental aid organisations such as Medecins Sans Frontieres.

Paul Cawthorn from MSF Thailand says the pharmaceutical industry's claims about its economic impact are exaggerated.

"C ompanies argue that if countries go down the road that Thailand's going down, then it eats into their profit margins and will put at risk research and development," he said.

"In fact if they were honest, advertising often eats up significantly large amounts of their profits than R and D does."

Source-Bio-Bio Technology

Related medicine news :

1. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
2. Pharma Companies May Influence The Decisions Of Medical Students
3. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
4. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
5. Doctors, Pharma Companies Targeted By CBI Raids
6. Raids Conducted In Hospitals And Pharmaceutical Companies
7. Australia to Show Leniency towards U.S. Pharmaceutical Companies
8. Pharma Companies Tie Up To Develop Bird Flu Vaccine
9. Companies Not Doing Enough To Fight Bird Flu
10. Food Companies show Pathetic Response to Health Crisis
11. Medicare Drug Plans Might Rest With Three Major Insurance Companies
Post Your Comments:

(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: